Antiretroviral News and Research

RSS
HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

Cabotegravir highly effective in preventing HIV among women

Cabotegravir highly effective in preventing HIV among women

Trial results show CAB LA is more effective in preventing HIV acquisition in women

Trial results show CAB LA is more effective in preventing HIV acquisition in women

Study identifies new cause of inflammation in people living with HIV

Study identifies new cause of inflammation in people living with HIV

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Study: Antiretroviral therapy fails to restore age-appropriate epigenetic patterns

Study: Antiretroviral therapy fails to restore age-appropriate epigenetic patterns

NIH awards $1.6 million for research on hormonal control of HIV latency

NIH awards $1.6 million for research on hormonal control of HIV latency

Researchers explore new method to monitor the effectiveness of HIV treatment at home

Researchers explore new method to monitor the effectiveness of HIV treatment at home

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

Glutathione precursor improves multiple deficits associated with premature aging

Glutathione precursor improves multiple deficits associated with premature aging

HIV self-tests improve "door-to-door" testing campaigns

HIV self-tests improve "door-to-door" testing campaigns

Researchers develop international policy index for HIV prevention among drug users

Researchers develop international policy index for HIV prevention among drug users

Study determines frequency and patterns of T-cell escape mutations in HIV patients undergoing antiretroviral therapy

Study determines frequency and patterns of T-cell escape mutations in HIV patients undergoing antiretroviral therapy

Study shows why antiretroviral therapy does not work in certain HIV patients

Study shows why antiretroviral therapy does not work in certain HIV patients

The implications of COVID-related sexual distancing and clinical service interruption

The implications of COVID-related sexual distancing and clinical service interruption